» Articles » PMID: 28266523

Abnormalities in A-to-I RNA Editing Patterns in CNS Injuries Correlate with Dynamic Changes in Cell Type Composition

Overview
Journal Sci Rep
Specialty Science
Date 2017 Mar 8
PMID 28266523
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Adenosine to Inosine (A-to-I) RNA editing is a co- or post-transcriptional mechanism that modifies genomically encoded nucleotides at the RNA level. A-to-I RNA editing is abundant in the brain, and altered editing levels have been reported in various neurological pathologies and following spinal cord injury (SCI). The prevailing concept is that the RNA editing process itself is dysregulated by brain pathologies. Here we analyzed recent RNA-seq data, and found that, except for few mammalian conserved editing sites, editing is significantly higher in neurons than in other cell populations of the brain. We studied A-to-I RNA editing in stab wound injury (SWI) and SCI models and showed that the apparent under-editing observed after injury correlates with an approximately 20% reduction in the relative density of neurons, due to cell death and immune cell infiltration that may account for the observed under-editing. Studies of neuronal and astrocyte cultures and a computational analysis of SCI RNA-seq data further supported the possibility that a reduction in neuronal density is responsible for alterations in the tissue-wide editing patterns upon injury. Thus, our data suggest that the case for a mechanistic linkage between A-to-I RNA editing and brain pathologies should be revisited.

Citing Articles

Quantification of AMPA receptor subunits and RNA editing-related proteins in the J20 mouse model of Alzheimer's disease by capillary western blotting.

Milham L, Morris G, Konen L, Rentsch P, Avgan N, Vissel B Front Mol Neurosci. 2024; 16:1338065.

PMID: 38299128 PMC: 10828003. DOI: 10.3389/fnmol.2023.1338065.


Recommendations for detection, validation, and evaluation of RNA editing events in cardiovascular and neurological/neurodegenerative diseases.

Karagianni K, Bibi A, Made A, Acharya S, Parkkonen M, Barbalata T Mol Ther Nucleic Acids. 2024; 35(1):102085.

PMID: 38192612 PMC: 10772297. DOI: 10.1016/j.omtn.2023.102085.


Changes in ADAR RNA editing patterns in CMV and ZIKV congenital infections.

Wales-McGrath B, Mercer H, Piontkivska H BMC Genomics. 2023; 24(1):685.

PMID: 37968596 PMC: 10652522. DOI: 10.1186/s12864-023-09778-4.


The Q/R editing site of AMPA receptor GluA2 subunit acts as an epigenetic switch regulating dendritic spines, neurodegeneration and cognitive deficits in Alzheimer's disease.

Wright A, Konen L, Mockett B, Morris G, Singh A, Burbano L Mol Neurodegener. 2023; 18(1):65.

PMID: 37759260 PMC: 10537207. DOI: 10.1186/s13024-023-00632-5.


A novel computational method enables RNA editome profiling during human hematopoiesis from scRNA-seq data.

Wu Y, Hao S, Xu X, Dong G, Ouyang W, Liu C Sci Rep. 2023; 13(1):10335.

PMID: 37365211 PMC: 10293275. DOI: 10.1038/s41598-023-37325-4.


References
1.
Ben-Gigi L, Sweetat S, Besser E, Fellig Y, Wiederhold T, Polakiewicz R . Astrogliosis Induced by Brain Injury Is Regulated by Sema4B Phosphorylation. eNeuro. 2015; 2(3). PMC: 4586933. DOI: 10.1523/ENEURO.0078-14.2015. View

2.
Maas S, Kawahara Y, Tamburro K, Nishikura K . A-to-I RNA editing and human disease. RNA Biol. 2006; 3(1):1-9. PMC: 2947206. DOI: 10.4161/rna.3.1.2495. View

3.
Nishikura K . Functions and regulation of RNA editing by ADAR deaminases. Annu Rev Biochem. 2010; 79:321-49. PMC: 2953425. DOI: 10.1146/annurev-biochem-060208-105251. View

4.
Rodriguez J, Menet J, Rosbash M . Nascent-seq indicates widespread cotranscriptional RNA editing in Drosophila. Mol Cell. 2012; 47(1):27-37. PMC: 3409466. DOI: 10.1016/j.molcel.2012.05.002. View

5.
Mannion N, Greenwood S, Young R, Cox S, Brindle J, Read D . The RNA-editing enzyme ADAR1 controls innate immune responses to RNA. Cell Rep. 2014; 9(4):1482-94. PMC: 4542304. DOI: 10.1016/j.celrep.2014.10.041. View